Irina Rodionova Selected Research

Colorectal Neoplasms (Colorectal Cancer)

9/2009

Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irina Rodionova Research Topics

Disease

1	Tuberculosis (Tuberculoses) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 09/2009
1	Stomatitis 09/2009

Drug/Important Bio-Agent (IBA)

1	NAD (NADH)IBA 01/2019
1	EnzymesIBA 01/2019
1	Antitubercular AgentsIBA 01/2019
1	nicotinic acid mononucleotide adenylyltransferase (nicotinate nucleotide adenylyltransferase)IBA 01/2019
1	Oral SpraysIBA 09/2009
1	Trefoil Factor-3IBA 09/2009
1	Fluorouracil (Carac)FDA LinkGeneric 09/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2009